Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Alcon spun off, leaner Novartis raises profit forecast

Alcon spun off, leaner Novartis raises profit forecast

These include rare disease gene therapy Zolgensma, breast cancer candidate alpelisib (BYL719)  and Lucentis follow-up brolucizumab.

Bayer to challenge Avastin legal ruling

Bayer to challenge Avastin legal ruling age-related macular degeneration (wet AMD) in place of two licensed but much more expensive treatments, Bayer’s Eylea and Novartis’ Lucentis. ... carried out to establish its equivalence in safety and efficacy with Lucentis in particular.

After Lucentis setback, Novartis trumpets data on follow-up drug

After Lucentis setback, Novartis trumpets data on follow-up drug of Lucentis and Eylea for AMD, even though Avastin isn’t approved for the indication. ... The US patents on Lucentis and Eylea will both expire in 2020, and in 2022 for Lucentis and 2021 for Eylea in Europe.

NHS wins legal fight with pharma over off-label Avastin

NHS wins legal fight with pharma over off-label Avastin and Novartis’ Lucentis  to treat wet AMD, claiming that it broke EU and UK laws governing medicines licensing. ... The cost implications are clear, as the court judgement showed: it says Avastin’s list price is around £28 per injection; Eylea

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III Allergan and partner Molecular Partners say a pair of two studies of abicipar show that the drug is non-inferior to monthly dosing with Roche and Novartis’ blockbuster Lucentis (ranibizumab) when ... The new drug could halve the number of injections

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics